Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
Journal article published in 2013 by
Martin Franz Sprinzl,
Florian Reisinger,
Andreas Puschnik,
Marc Ringelhan,
Kerstin Ackermann,
Daniel Hartmann,
Matthias Schiemann,
Arndt Weinmann,
Peter Robert Galle,
Marcus Schuchmann,
Helmut Friess,
Gerd Otto,
Mathias Heikenwalder,
Ulrike Protzer
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 